imipenem, anhydrous has been researched along with Infections, Klebsiella in 179 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (2.23) | 18.7374 |
| 1990's | 14 (7.82) | 18.2507 |
| 2000's | 48 (26.82) | 29.6817 |
| 2010's | 85 (47.49) | 24.3611 |
| 2020's | 28 (15.64) | 2.80 |
| Authors | Studies |
|---|---|
| Cornaglia, G; Koncan, R; Mazzariol, A; Roelofsen, E; Voss, A | 1 |
| Carmeli, Y; Chmelnitsky, I; Leavitt, A; Navon-Venezia, S; Schwaber, MJ | 1 |
| Cuzon, G; Demachy, MC; Naas, T; Nordmann, P | 1 |
| Cuzon, G; Lartigue, MF; Naas, T; Nordmann, P; Quinn, JP; Villegas, MV | 1 |
| Bethel, CR; Bonomo, RA; Carias, LL; Endimiani, A; Fox, WR; Hall, GS; Hujer, AM; Hujer, KM; Hutton, RA; Jacobs, MR; Jenkins, SG; Paterson, DL; Perez, F; Rice, LB; Tenover, FC | 1 |
| Apisarnthanarak, A; Kiratisin, P; Laesripa, C; Saifon, P | 1 |
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Bogaerts, P; Cuzon, G; Glupczynski, Y; Huang, TD; Naas, T; Nordmann, P | 1 |
| Arpin, C; Bezian, MC; Coulange, L; Demarthe, F; Dubois, V; Minarini, LA; Nordmann, P; Poirel, L; Quentin, C | 1 |
| Della-Latta, P; Dib-Hajj, F; Dougherty, BA; Gootz, TD; He, W; Huard, RC; Lescoe, MK | 1 |
| Baraniak, A; Fiett, J; Filczak, K; Gniadkowski, M; Herda, M; Hryniewicz, W; Izdebski, R; Kern-Zdanowicz, I; Łopaciuk, U | 1 |
| Chung, DR; Ko, KS; Peck, KR; Son, JS; Song, JH; Suh, JY | 1 |
| Cho, HS; Giske, CG; Lee, K; Sundman, K; Toleman, MA; Walsh, TR; Yong, D | 1 |
| Albertí, S; Bengoechea, JA; Doménech-Sánchez, A; Llobet, E; Martínez-Martínez, L; Padilla, E | 1 |
| Choi, JY; Ko, KS; Lee, MY; Park, YK; Peck, KR; Rhee, JY; Shin, JY; Song, JH | 1 |
| Carmeli, Y; Chmelnitsky, I; Goren, MG; Leavitt, A; Navon-Venezia, S; Ofek, I | 1 |
| Badal, RE; Baquero, F; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ | 1 |
| Bonomo, RA; Endimiani, A; Hujer, AM; Hujer, KM; Pulse, ME; Weiss, WJ | 1 |
| Bernabeu, S; Nordmann, P; Poirel, L; Revathi, G | 1 |
| Campagne, JM; Gerber, C; Gualtieri, M; Marcia de Figueiredo, R; Midrier, C; Pantel, L; Racine, E; Sarciaux, M; Serri, M; Villain-Guillot, P | 1 |
| Chai, Z; Liu, H; Liu, J; Lu, J; Min, Z; Muhammad, M; Yang, Y; Zhang, L | 1 |
| Haider Naqvi, SZ; Malik, A; Muddassir, M; Mumtaz, K; Munir, S; Raza, A; Shoaib Ahmed, S; Waqas, K | 1 |
| Chen, Y; Luo, Q; Qiu, Y; Shen, P; Xiao, Y; Xu, H; Yu, W | 1 |
| Li, S; Liu, W; Mo, Q; Shao, M; Sun, L; Ying, N; Zhu, L | 1 |
| Ambretti, S; Gaibani, P; Lazzarotto, T; Lombardo, D | 1 |
| Lin, Z; Liu, S; Yu, J; Zhu, M | 1 |
| Amadesi, S; Ambretti, S; Bartoletti, M; Bovo, F; Bussini, L; Gaibani, P; Lazzarotto, T; Viale, P | 1 |
| Chen, H; Li, N; Liang, W; Wang, F; Wang, L | 1 |
| Akrami, S; Alkhudhairy, MK; Benyagoub, E; Raouf, FEA; Saki, M | 1 |
| Al Atbee, MYN; Jalil, MB | 1 |
| Cai, H; Guo, Q; He, T; Li, D; Wang, D; Wang, M; Xu, X; Yuan, Y | 1 |
| Findlay, J; Nordmann, P; Poirel, L; Rens, C | 1 |
| Bandić-Pavlović, D; Barišić, I; Beader, N; Bedenić, B; Frančula-Zaninović, S; Krilanović, M; Pešorda, L; Schoenthaler, S; Veir, Z | 1 |
| Fang, SB; Fujisawa, M; Kado, M; Maeda, K; Onishi, R; Osawa, K; Shigemura, K; Tanimoto, H; Yang, YM | 1 |
| Deng, Y; Huang, W; Li, J; Qiao, F; Zhang, W; Zhu, S; Zong, Z | 1 |
| Shamsuzzaman, SM; Sonia, SJ; Uddin, KH | 1 |
| Lukovic, B; Petrovic, I; Zornic, S | 1 |
| Akrami, S; Al-Dahmoshi, HOM; Al-Khafaji, NSK; Bannazadeh Baghi, H; Jafari-Sales, A; Judi, HK; Nasiri, R; Sadeghi Deylamdeh, Z; Saki, M; Shariat, A | 1 |
| Goudarzi, G; Shakib, P | 1 |
| Esmail, MAM; Khairy, RMM; Mahmoud, MS; Shady, RR | 1 |
| Al-Zaban, MI; AlHarbi, MA; Azim, NSA; Nofal, MY; Somily, AM | 1 |
| Antinori, E; Bertoncelli, A; Mazzariol, A; Unali, I | 1 |
| Adeleye, AI; Ajayi, A; Akinpelu, S; Smith, SI | 1 |
| Cao, J; Dhanasekaran, V; Fang, R; Li, J; Lithgow, T; Liu, H; Perlaza-Jiménez, L; Tian, X; Wang, C; Wang, Q; Zhao, Y; Zheng, X; Zhou, T | 1 |
| Hirabayashi, A; Kajihara, T; Shibayama, K; Sugai, M; Yahara, K | 1 |
| Bian, W; Chen, W; Gu, X; Liu, Y; Qin, Y; Wang, S; Zhao, G | 1 |
| Borghi, M; Devereux, M; Ferreira Ventura, R; FerreiraNunes, AP; McCann, M; Pinto Schuenck, R; Souza Dos Santos, AL; Vianez Peregrino, I | 1 |
| Blasco, L; Bleriot, I; Bou, G; Domingo-Calap, P; Fernández-Cuenca, F; Fernández-García, L; González-Bardanca, M; López, M; Martínez-Martínez, L; Oteo, J; Pacios, O; Pascual, Á; Tomás, M | 1 |
| Cai, J; Cui, W; Huang, J; Qian, Z; Song, F; Zhang, G; Zhang, K; Zheng, C; Zhou, F; Zhou, H | 1 |
| Astashkin, EI; Ershova, ON; Fursova, NK; Kartsev, NN; Lev, AI; Platonov, ME; Shaikhutdinova, RZ; Svetoch, EA; Volozhantsev, NV | 1 |
| Aires, CAM; Albano, RM; Asensi, MD; Carvalho-Assef, APD; da Conceição-Neto, OC; Dias, CF; Montezzi, LF; Picão, RC; Tavares E Oliveira, TR | 1 |
| Kramer, J; Proschak, A; Proschak, E; Wichelhaus, TA | 1 |
| Badal, R; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
| Arlet, G; Boutiba-Ben Boubaker, I; Ferjani, S; Fernandez Martinez, M; Genel, N; Hammami, S; Hamzaoui, Z; Harbaoui, S; Maamar, E; Martinez-Martinez, L; Ocampo-Sosa, A; Saidani, M; Slim, A | 1 |
| Cha, MK; Chung, DR; Kang, CI; Kim, SH; Lee, NY; Peck, KR; Song, JH | 1 |
| Bogaerts, P; Bonnin, RA; Dabos, L; Glupczynski, Y; Huang, DT; Iorga, BI; Naas, T; Sacré, P; Zavala, A | 1 |
| Atrkar Roushan, Z; Ghaffarian, F; Hedayati, M; Mojtahedi, A; Sedigh Ebrahim-Saraie, H | 1 |
| Ejaz, A; Ejaz, H; Javed, H; Saleem, R; Younas, S; Zafar, A | 1 |
| Abdul Jabar, K; Chai, LC; Chong, CW; Clarke, SC; Low, YM; Md Yusof, MY; Ponnampalavanar, S; Teh, CSJ; Yap, IKS | 1 |
| Bao, C; Chin, W; Ding, B; Fan, W; Gao, S; Hedrick, JL; Hsu, LY; Lee, A; Leong, J; Lou, W; Pu, Q; Tan, JPK; Wu, M; Xu, L; Yang, C; Yang, YY; Zhong, G | 1 |
| Al-Bustan, SA; Alkhudhairy, MK; Alshadeedi, SMJ; Ghasemian, A; Mahmood, SS | 1 |
| Jiang, C; Liu, L; Liu, N; Xie, N; Xu, Y; Zhang, G | 1 |
| Bou Casals, J; Daikos, GL; Kotsakis, SD; Miriagou, V; Tzelepi, E; Tzouvelekis, LS | 1 |
| Harino, T; Kashiyama, S; Kayama, S; Kuwahara, R; Ohge, H; Onodera, M; Shigemoto, N; Sugai, M; Yokozaki, M | 1 |
| Arslan, H; Azap, OK; Çolakoğlu, Ş; Evren, E | 1 |
| Damjanova, I; Kádár, B; Kocsis, B; Kristóf, K; Nagy, K; Szabó, D; Szász, M; Tóth, Á | 1 |
| Imon, K; Ishino, T; Kayama, S; Kuwahara, R; Ohge, H; Onodera, M; Shigemoto, N; Sugai, M; Yokozaki, M | 1 |
| Biçmen, M; Gülay, Z; Sarı, AN | 1 |
| Abercrombie, JJ; Chen, P; Leung, KP; Mustoe, TA; Seth, AK | 1 |
| Belghiti, J; Bert, F; Dondero, F; Durand, F; Larroque, B; Moreau, R; Nicolas-Chanoine, MH; Paugam-Burtz, C | 1 |
| Bonomo, RA; Cline, M; Cober, E; Conlan, S; Evans, S; Fowler, VG; Fox, J; Hall, GS; Hanrahan, J; Jacobs, MR; Kalayjian, RC; Kaye, KS; Mason, P; Perez, F; Richter, SS; Rudin, SD; Salata, RA; Segre, JA; van Duin, D; Webber, R; Ziegler, J | 1 |
| Aissa, N; Bertrand, X; Blanc, V; Cavalié, L; de Champs, C; Eloy, C; Guyeux, C; Hocquet, D; Lavigne, JP; Liapis, E; Nicolas-Chanoine, MH; Pantel, A; Robert, J; van der Mee-Marquet, N | 1 |
| Gu, B; Mei, Y; Wen, Y; Xia, W; Zhang, X | 1 |
| Kim, KH; Lee, JY | 1 |
| Chen, Z; Li, L; Sun, Z; Tian, L; Wang, Y; Yan, S; Zhang, B; Zhu, X | 1 |
| Mangin, E; Mavridou, E; Melchers, RJ; Motyl, MR; Mouton, JW; van Mil, AC | 1 |
| Ahn, S; Han, WD; Kim, ES; Kim, HB; Kim, NH; Kim, TS; Park, KU; Seo, HK; Shin, MJ; Song, KH; Yoo, JS | 1 |
| Cao, XW; Deng, Q; Liu, Y; Wan, LG; Wei, DD; Xu, QF; Yu, Y | 1 |
| Cuesta-Bernal, J; El-Delik, J; Frank, D; Göttig, S; Klingler, FM; Koenigs, A; Müller, HF; Pogoryelov, D; Pos, KM; Proschak, E; Sjuts, H; Wichelhaus, TA | 1 |
| Abdelhaleim, M; AbdulRahman, E; Ghaith, D; Wassef, M | 1 |
| Chuang, YC; Ku, YH; Lee, MF; Tang, HJ; Yu, WL | 1 |
| Gentry, CA; Williams, RJ | 1 |
| Chan, YJ; Chuang, C; Chuang, YC; Fung, CP; Huang, CT; Lin, YT; Siu, LK; Su, CF; Wang, LS | 1 |
| De Luca, F; Docquier, JD; Hrabák, J; Papagiannitsis, CC; Pollini, S; Rossolini, GM | 1 |
| Chongtrakool, P; Diraphat, P; Malathum, K; Pornsinchai, P; Siripanichgon, K | 1 |
| Barrios, H; Carrillo-Casas, EM; Garza-Ramos, U; Hernández-Castro, R; Moncada-Barron, D; Moreno-Dominguez, S; Reyna-Flores, F; Sanchez-León, MC; Sanchez-Perez, A; Silva-Sanchez, J | 1 |
| Hung, YP; Ko, WC; Lee, JC; Li, CW; Li, MC; Lin, HJ; Liu, HC; Wu, YH | 1 |
| Calfee, DP; Eiras, DP; Furuya, EY; Gomez-Simmonds, A; Jenkins, SG; Kubin, CJ; Loo, A; Nelson, B; Satlin, MJ; Whittier, S | 1 |
| Damjanova, I; Fenyvesi, H; Jakab, G; Jánvári, L; Kovács, K; Melegh, S; Mestyán, G; Nyul, A; Szabó, H; Tóth, Á | 1 |
| Aracil-García, B; Campos, J; Cuevas-Lobato, Ó; Fernández-Romero, S; Lara-Fuella, N; Oteo-Iglesias, J; Pérez-Grajera, I; Pérez-Vázquez, M | 1 |
| Ciszek, M; Dobrzaniecka, K; Grochowiecki, T; Grygiel, K; Młynarczyk, G; Pączek, L; Sańko-Resmer, J; Wilkowski, P; Łabuś, A | 1 |
| Chan, YJ; Chuang, C; Chuang, YC; Fung, CP; Lin, YT; Siu, LK; Su, CF; Wang, FD; Wu, PF | 1 |
| Battikh, H; Dekhili, A; Fendri, C; Harchay, C; Kechrid, F; Khazar, K; Masmoudi, A; Zribi, M | 1 |
| Ahmad, I; Akhtar, T; Ambreen, A; Gandapor, AJ; Khan, A; Khan, AM; Ullah, O | 1 |
| Ajao, AO; Albrecht, JS; Furuno, JP; Harris, AD; Johnson, JK; Pineles, LL; Robinson, GL; Thom, KA; Zhao, L | 1 |
| Douzinas, EE; Legakis, NJ; Miriagou, V; Papagiannitsis, CC; Piperaki, E; Tzouvelekis, LS | 1 |
| Guo, Y; Yang, D; Zhang, Z | 1 |
| Espinal-Witter, R; Larone, DH; Morgan, DJ; Weisenberg, SA | 1 |
| Ahmad, S; Al-Juaid, NF; Alenzi, FQ; Bakheet, Oel-S; Mattar, EH | 1 |
| Choe, KW; Jeon, JH; Kim, HB; Kim, NJ; Lee, HS; Oh, MD; Park, SW; Park, WB; Song, KH | 1 |
| Ahmadi, S; Bazzaz, BS; Farshadzadeh, Z; Mohamadpoor, AH; Naderinasab, M; Yousefi, F | 1 |
| Balan, G; Lim, KT; Md Yasin, R; Thong, KL; Yeo, CC | 1 |
| Faccone, D; Galas, M; López, Y; Maggi, G; Marcano, D; Pasterán, F; Payares, D; Rapoport, M; Salgado, N; Sánchez, D; Spadola, E; Ugarte, C | 1 |
| Cuzon, G; Guibert, M; Naas, T; Nordmann, P | 1 |
| Bragatti, JA; Cabral, L; Finkelsztejn, A; Schuh, AF; Silva, AV | 1 |
| Daikos, GL; Douzinas, E; Legakis, NJ; Miriagou, V; Tsakiri, M; Tzelepi, E; Tzouvelekis, LS; Zioga, A | 1 |
| Chong, Y; Kim, JJ; Kim, S; Koh, E; Lee, CH; Lee, J; Lee, K; Lee, MA; Roh, KH; Yong, D | 1 |
| Aygencel, G; Dizbay, M | 1 |
| Barsaoui, S; Ben Jaballah, N; Bousnina, S; Bouziri, A; Hajji, N; Hariga, D; Kechrid, A; Sammoud, A; Smaoui, H | 1 |
| Abbanat, D; Barron, A; Bunting, RA; Fernandez, J; Flamm, RK; Hall, L; Hilliard, JJ; Lynch, AS; Melton, JL; Ward, CK | 1 |
| Arlet, G; Boutelier, C; Carbonne, A; Castaing, D; Decre, D; Dussaix, E; Gastiaburu, N; Guerin, C; Jarlier, V; Kassis-Chikhani, N; Lavigne-Kriaa, A; Neuville, S; Saliba, F; Samuel, D; Sengelin, C | 1 |
| Cai, J; Liu, J; Wu, D | 1 |
| Chiang, T; Colon-Urban, R; Eng, RH; Gomez, E; Huang, DB; Mariano, N; Urban, C | 1 |
| Ersoy, Y; Görgeç, S; Kuzucu, C; Yetkin, F | 1 |
| Basu, S; Das, P; Roy, S; Singh, AK; Viswanathan, R | 1 |
| Hsueh, PR; Huang, WH; Ko, WC; Lee, NY; Tsui, KC | 1 |
| Raghunathan, A; Samuel, L; Tibbetts, RJ | 1 |
| Badal, RE; Bouchillon, SK; Hackel, M; Hawser, SP; Hoban, DJ; Lascols, C; Livermore, DM; Woodford, N | 1 |
| Hisatsune, J; Kato, F; Kayama, S; Kuwahara, R; Ohge, H; Onodera, M; Shigemoto, N; Shimizu, W; Sugai, M; Yokozaki, M | 1 |
| Hisatsune, J; Kato, F; Kayama, S; Kuwahara, R; Ohge, H; Onodera, M; Shigemoto, N; Sugai, M; Yokozaki, M | 1 |
| Maherault, AC; Nordmann, P; Pangon, B; Therby, A | 1 |
| Cao, W; Chen, Z; Li, L; Liu, C; Sun, Z; Tian, L; Wang, B; Wang, F; Wang, Y; Zhang, B; Zhu, X | 1 |
| Couet, W; Grégoire, N; Marliat, M; Mimoz, O; Nordmann, P; Poirel, L | 1 |
| Bhagunde, P; Chang, KT; Hirsch, EB; Ledesma, KR; Nikolaou, M; Tam, VH | 1 |
| Hsueh, PR; Huang, WH; Ko, WC; Lee, CC; Lee, NY; Tsui, KC | 1 |
| Anderson, DJ; Bennett, KM; Dotson, TL; Sarraf-Yazdi, S; Sharpe, M; Vaslef, SN | 1 |
| Aleo, A; Bonura, C; Brunelli, T; Degl'Innocenti, R; Fasciana, T; Mammina, C; Nastasi, A; Pesavento, G | 1 |
| Bansal, N; Chander, J; Gupta, V; Singla, N | 1 |
| Boyle, F; Boyle, L; Brisse, S; Burns, K; Condon, I; Cormican, M; Delannoy-Vieillard, AS; Finnegan, C; Humphreys, H; Khan, A; Monahan, R; Morris, C; Morris, D; Morris-Downes, M; O'Connell, N; O'Gorman, A; Powell, J; Power, L; Turton, J; Woodford, N | 1 |
| Aiello, E; D'Ancona, F; Dematte, L; Goglio, A; Meledandri, M; Pantosti, A; Raglio, A; Rossolini, GM; Serra, R; Sisto, A | 1 |
| Hsieh, MH; Lu, PL; Ma, L; Siu, LK | 1 |
| Chen, H; Li, Z; Shen, W; Yuehua, X; Zhou, H; Zhou, L | 1 |
| Colakoğlu, S; Durmaz, S; Ekincioğlu, P; Perçin, D | 1 |
| Chen, P; Cheng, WC; Xiang, XD; Zan, JN | 1 |
| Cimiotti, J; Della-Latta, P; Gupta, A; Larson, E; Loughrey, M; Rubenstein, D; Saiman, L; Stone, PW | 1 |
| Amicosante, G; Colì, A; Endimiani, A; Lombardi, G; Luzzaro, F; Perilli, M; Tamborini, A; Toniolo, A | 1 |
| Bonomo, RA; Casellas, JM; Goossens, H; Klugman, KP; Ko, WC; McCormack, JG; Mohapatra, S; Mulazimoglu, L; Paterson, DL; Rice, LB; Trenholme, G; Von Gottberg, A; Wagener, MM; Yu, VL | 1 |
| Cho, YK; Kim, SY; Lee, ES; Lee, SO; Park, SY; Seo, YH | 1 |
| Cassettari, VC; Gales, AC; Lincopan, N; Mamizuka, EM; McCulloch, JA; Reinert, C | 1 |
| Bernabéu-Wittel, M; de Cueto, M; del Carmen Conejo, M; García, I; Jiménez-Mejías, ME; Martínez-Martínez, L; Pachón, J; Pachón-Ibáñez, ME; Pascual, A; Pichardo, C | 1 |
| Conejo, C; Ibáñez-Martínez, J; Martínez-Martínez, L; Pachón, J; Pachón-Ibañez, ME; Pascual, A; Pichardo, C; Rodríguez-Martínez, JM | 1 |
| Arlet, G; Bidet, P; Bingen, E; Brahimi, N; Burghoffer, B; El-Ghoneimi, A; Gautier, V; Mariani-Kurkdjian, P | 1 |
| Bratu, S; Landman, D; Quale, J; Salvani, JK | 1 |
| Chong, Y; Ha, GY; Jeong, SH; Lee, K; Lim, HS; Park, KH; Shin, JH; Yong, D | 1 |
| Albertí, S; Alonso, D; Borrell, N; Doménech-Sánchez, A; Gomez, C; Padilla, E; Pérez, JL | 1 |
| Kim, HS; Kim, SY; Lee, K; Park, YJ; Park, YS; Yoo, JY; Yoon, JB; Yu, JK | 1 |
| Jakoniuk, P; Leszczyńska, K; Sacha, PT; Wieczorek, P; Zalewska, M | 1 |
| Avlami, A; Daikos, GL; Gargalianos, P; Karabinis, A; Kosmidis, C; Malamou-Lada, H; Paramythiotou, E; Petropoulou, D; Syriopoulou, VP; Tzanetou, K | 1 |
| Anderlik, P; Máthé, A; Nagy, K; Rozgonyi, F; Szabó, D | 1 |
| Bae, IK; Bae, SJ; Jeong, SH; Lee, JH; Lee, SH | 1 |
| Gin, GG; Karunakaran, R; Muniandy, S; Palasubramaniam, S; Parasakthi, N | 1 |
| Carrero, HA; Erwin, DP; Ewell, AJ; Mody, RM; Moran, KA; Selby, EB; Summers, AM | 1 |
| Donskey, CJ; Pultz, MJ | 1 |
| Chen, YS; Chiu, CJ; Chu, C; Lee, CH; Liu, JW; Su, LH | 1 |
| Guglielmo, BJ; Yang, K | 1 |
| Ivanov, DV | 1 |
| Etoh, T; Hirose, M; Ishibashi, H; Muro, H; Ohta, S; Shirasu, T; Suzuki, K; Tanio, N | 1 |
| Conejo, MC; Hernández, JR; Pascual, A | 1 |
| Alford, RH; Brown, TH | 1 |
| Ehrhardt, AF; Sanders, CC; Thomson, KS; Trujillano-Martin, I; Watanakunakorn, C | 1 |
| Grayson, ML; Stuart, RL; Turnidge, J | 1 |
| Goto, S; Matsunaga, T; Nagashima, M; Ogawa, M; Shimohira, H; Yoshida, T | 1 |
| Bradford, PA; Bush, K; Mariano, N; Projan, SJ; Rahal, JJ; Urban, C | 1 |
| Confino-Cohen, R; Goldberg, A; Lang, R | 1 |
| Amyes, SG; Dorai-John, T; Forbes, KJ; Gould, IM; MacKenzie, FM | 1 |
| Adhikari, M; Pillay, DG; Pillay, T; Sturm, AW | 1 |
| Burns, JM; Dominick, D; Freeman, K; Horn, D; Lim, M; Mariano, N; Marks, S; Maurer, J; Rahal, JJ; Segal-Maurer, S; Urban, C | 1 |
| Lawrence, C; Nauciel, C; Ronco, E | 1 |
| Nagy, E; Pragai, Z | 1 |
| Ahmad, M; Bradford, PA; Bush, K; Calcagni, E; Mariano, N; Projan, SJ; Rahal, JJ; Urban, C | 1 |
| Anderlik, P; Filetóth, Z; Máthé, A; Rókusz, L; Rozgonyi, F; Szabó, D | 1 |
| Hostacká, A | 1 |
| Díez García, F; Gallego Rojo, FJ; Salas Coronas, J; Sánchez Sánchez, JC | 1 |
| Goodwin, CS; Nsanze, H; Topley, J; Varady, E; Worsley, BW | 1 |
| Aubert, G; Boylot, D; Brunon, J; Dorche, G; Duthel, R; Jacquemond, G; Pozzetto, B | 1 |
| Amano, H; Kawazu, H; Nishiwaki, K; Saito, H; Saka, H; Sakai, S; Senda, Y; Shimokata, K; Torii, Y; Yamamoto, M | 1 |
| Calame, W; Craig, WA; Ebert, S; Fantin, B; Leggett, JE; Mattie, H; Totsuka, K; Vogelman, B | 1 |
| Casali, W; Cogo, R; Falchi, M; Fraschini, F; Gattei, G; Scaglione, F | 1 |
| Chadwick, EG; Shulman, ST; Yogev, R | 1 |
1 review(s) available for imipenem, anhydrous and Infections, Klebsiella
| Article | Year |
|---|---|
Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins | 2007 |
2 trial(s) available for imipenem, anhydrous and Infections, Klebsiella
| Article | Year |
|---|---|
Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum beta-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin.
Topics: Bacteremia; beta-Lactamases; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 2004 |
Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella.
Topics: Adult; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Utilization Review; Guideline Adherence; Hospital Bed Capacity, 500 and over; Hospitals, Community; Humans; Imipenem; Incidence; Infection Control; Klebsiella; Klebsiella Infections; New York City; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1998 |
176 other study(ies) available for imipenem, anhydrous and Infections, Klebsiella
| Article | Year |
|---|---|
Detection of a new SHV-type extended-spectrum beta-lactamase, SHV-31, in a Klebsiella pneumoniae strain causing a large nosocomial outbreak in The Netherlands.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Netherlands; Plasmids | 2007 |
Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Hospitals; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology | 2007 |
Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Female; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2008 |
Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene.
Topics: Base Sequence; beta-Lactamases; beta-Lactams; Cloning, Molecular; Colombia; DNA Transposable Elements; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA; United States | 2008 |
Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.
Topics: Aged; Bacterial Proteins; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Quinolones; United States | 2008 |
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
Topics: Adult; Bacterial Proteins; beta-Lactamases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Polymerase Chain Reaction; Sequence Analysis, DNA; Thailand | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Plasmid-encoded carbapenem-hydrolyzing beta-lactamase OXA-48 in an imipenem-susceptible Klebsiella pneumoniae strain from Belgium.
Topics: Adult; Anti-Bacterial Agents; Belgium; beta-Lactamases; beta-Lactams; Carbapenems; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids | 2008 |
Molecular and biochemical characterization of SHV-56, a novel inhibitor-resistant beta-lactamase from Klebsiella pneumoniae.
Topics: Aged; Amino Acid Substitution; Base Sequence; beta-Lactam Resistance; beta-Lactamases; DNA Primers; DNA, Bacterial; Female; Genes, Bacterial; Humans; Isoelectric Point; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Mutagenesis, Insertional; Recombinant Proteins | 2008 |
Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA Transposable Elements; Drug Resistance, Bacterial; Hospitals, Urban; Humans; Isoenzymes; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Microbial Sensitivity Tests; New York City; Plasmids; Transposases | 2009 |
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Sequence Data; Poland | 2009 |
Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea.
Topics: Anti-Bacterial Agents; Bacteremia; Colistin; Cross Infection; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Population Surveillance; Republic of Korea | 2010 |
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carboxylic Ester Hydrolases; Cefotaxime; Cefuroxime; Cephalosporins; Cephalothin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; India; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2009 |
Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence.
Topics: Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Culture Media; Defensins; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lipopolysaccharides; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Phenotype; Plasmids; Polymyxin B; Polysaccharides; Repressor Proteins; RNA, Bacterial | 2010 |
KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea.
Topics: Aged; beta-Lactamases; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Male; Renal Dialysis; Republic of Korea | 2010 |
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Phylogeny; Plasmids; Polymerase Chain Reaction | 2010 |
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrob
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2010 |
Evaluation of ceftazidime and NXL104 in two murine models of infection due to KPC-producing Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Disease Models, Animal; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Sepsis | 2011 |
Detection of NDM-1-producing Klebsiella pneumoniae in Kenya.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Kenya; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction | 2011 |
Total Synthesis and Structure-Activity Relationships Study of Odilorhabdins, a New Class of Peptides Showing Potent Antibacterial Activity.
Topics: Animals; Anti-Bacterial Agents; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Molecular Structure; Peptide Fragments; Protein Biosynthesis; Respiratory Tract Infections; Ribosome Subunits, Small; Structure-Activity Relationship; Xenorhabdus | 2018 |
Factors behind the prevalence of carbapenem-resistant Klebsiella pneumoniae in pediatric wards.
Topics: Adult; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Child; Child, Preschool; China; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Infant; Infant, Newborn; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Male; Maternal-Child Health Services; Pregnancy | 2021 |
Antibiogram and molecular characterization of multi-drug resistant microorganisms isolated from urinary tract infections.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nitrofurantoin; Oxacillin; Pakistan; Pipemidic Acid; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2021 |
New options for bloodstream infections caused by colistin- or ceftazidime/avibactam-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacteremia; beta-Lactamase Inhibitors; Boronic Acids; Carbapenem-Resistant Enterobacteriaceae; Ceftazidime; Cilastatin; Colistin; Drug Combinations; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Tetracyclines | 2021 |
Machine learning for identifying resistance features of
Topics: Amikacin; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Machine Learning; Microbial Sensitivity Tests; Polymorphism, Single Nucleotide; Tetracyclines | 2021 |
In vitro activity of imipenem-relebactam against KPC-producing Klebsiella pneumoniae resistant to ceftazidime-avibactam and/or meropenem-vaborbactam.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Boronic Acids; Ceftazidime; Drug Combinations; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2022 |
Prevalence and antibiotic resistance of
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prevalence; Tertiary Care Centers | 2022 |
Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatments.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cilastatin; Drug Combinations; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Carbapenem antibiotic stress increases bla
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; DNA Copy Number Variations; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Extended-spectrum beta-lactamases among Klebsiella pneumoniae from Iraqi patients with community-acquired pneumonia.
Topics: Anti-Bacterial Agents; beta-Lactamases; Humans; Imipenem; Iraq; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Norfloxacin; Pneumonia | 2022 |
The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections.
Topics: Ampicillin; Anti-Bacterial Agents; Aztreonam; Cefepime; Ceftazidime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Piperacillin; Prevalence; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2022 |
High-level ertapenem resistance in Klebsiella pneumoniae is due to RamA downregulation of ompK35 through micF.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Down-Regulation; Ertapenem; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Sodium Dodecyl Sulfate | 2022 |
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Escherichia coli; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2022 |
Evolution of Beta-Lactamases in Urinary Klebsiella pneumoniae Isolates from Croatia; from Extended-Spectrum Beta-Lactamases to Carbapenemases and Colistin Resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Colistin; Croatia; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2022 |
Molecular characteristics and genetic analysis of the genes related to carbapenemase, efflux pump, and outer membrane proteins in carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Porins | 2023 |
Analysis of risk factors associated with healthcare-associated carbapenem-resistant Klebsiella pneumoniae infection in a large general hospital: a case-case-control study.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cross Infection; Delivery of Health Care; Drug Resistance, Bacterial; Hospitals, General; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors | 2023 |
Carbapenem Resistance among Klebsiella pneumoniae in a Tertiary Care Hospital in Bangladesh.
Topics: Agar; Anti-Bacterial Agents; Bangladesh; beta-Lactamases; Carbapenems; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tertiary Care Centers | 2023 |
In vitro activity of imipenem/relebactam and ceftazidime/avibactam against carbapenem-resistant Klebsiella pneumoniae from blood cultures in a University hospital in Serbia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Colistin; Drug Combinations; Hospitals, University; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serbia | 2023 |
Occurrence of some common carbapenemase genes in carbapenem-resistant Klebsiella pneumoniae isolates collected from clinical samples in Tabriz, northwestern Iran.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross-Sectional Studies; Humans; Imipenem; Iran; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2023 |
The Occurrence of bla
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Bacterial; Humans; Imipenem; Iran; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nalidixic Acid; Trimethoprim, Sulfamethoxazole Drug Combination | 2020 |
Multidrug-resistant Klebsiella pneumoniae in hospital-acquired infections: Concomitant analysis of antimicrobial resistant strains.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Child; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Phenotype; Young Adult | 2020 |
Molecular-diversity, Prevalence and Antibiotic Susceptibility of Pathogenic Klebsiella Pneumoniae under Saudi Condition.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Ceftriaxone; DNA, Bacterial; Female; Genetic Variation; Genotype; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Saudi Arabia; Virulence | 2019 |
Klebsiella pneumoniae carbapenemase (KPC) producer resistant to ceftazidime-avibactam due to a deletion in the blaKPC3 gene.
Topics: Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftazidime; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Sequence Analysis, DNA; Sequence Deletion | 2020 |
Efflux pump activity, biofilm formation and antibiotic resistance profile of Klebsiella spp. isolated from clinical samples at Lagos University Teaching Hospital.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Biofilms; Cefuroxime; Cells, Cultured; Community-Acquired Infections; Drug Combinations; Drug Resistance, Multiple, Bacterial; Hospitals, Teaching; Hospitals, University; Humans; Imipenem; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Nigeria; Ofloxacin; Tertiary Care Centers | 2020 |
First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fosfomycin; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Phylogeny; Plasmids; Virulence Factors; Whole Genome Sequencing | 2020 |
Geographical distribution of Enterobacterales with a carbapenemase IMP-6 phenotype and its association with antimicrobial use: An analysis using comprehensive national surveillance data on antimicrobial resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Japan; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Phenotype | 2020 |
[Analysis of related factors of carbapenem resistant Klebsiella pneumoniae infection in patients with artificial airway].
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors | 2020 |
Antibacterial activity and carbapenem re-sensitizing ability of 1,10-phenanthroline-5,6-dione and its metal complexes against KPC-producing Klebsiella pneumoniae clinical strains.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Coordination Complexes; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Phenanthrolines | 2021 |
Enhanced Antibacterial Activity of Repurposed Mitomycin C and Imipenem in Combination with the Lytic Phage vB_KpnM-VAC13 against Clinical Isolates of Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacteriophages; beta-Lactamases; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mitomycin | 2021 |
Clinical Characteristics, Risk Factors, and Outcomes of Patients with Polymicrobial
Topics: Adult; Aged; Bacteremia; Carbapenems; Ertapenem; Female; Hospitalization; Humans; Imipenem; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2021 |
Identification of IS1R and IS10R elements inserted into ompk36 porin gene of two multidrug-resistant Klebsiella pneumoniae hospital strains.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cloning, Molecular; Databases, Genetic; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Imipenem; Integrons; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins; Sequence Analysis, DNA | 2017 |
Emergence of the Plasmid-Mediated
Topics: Anti-Bacterial Agents; beta-Lactamases; Brazil; Colistin; Drug Resistance, Bacterial; Escherichia coli Proteins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Plasmids | 2017 |
Bacterial zincophore [S,S]-ethylenediamine-N,N'-disuccinic acid is an effective inhibitor of MBLs.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Disease Models, Animal; Enzyme Inhibitors; Ethylenediamines; Gram-Negative Bacteria; Imipenem; Klebsiella Infections; Lepidoptera; Microbial Sensitivity Tests; Succinates; Survival Analysis; Treatment Outcome | 2018 |
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Incidence; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2017 |
An Outbreak of NDM-1-Producing Klebsiella pneumoniae, Associated with OmpK35 and OmpK36 Porin Loss in Tunisia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Disease Outbreaks; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Porins; Tunisia | 2018 |
High Prevalence of CTX-M-15-Type Extended-Spectrum β-Lactamase Among AmpC β-Lactamase-Producing Klebsiella pneumoniae Isolates Causing Bacteremia in Korea.
Topics: Bacteremia; Bacterial Proteins; beta-Lactamases; Genes, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Republic of Korea | 2018 |
Genetic and Biochemical Characterization of OXA-519, a Novel OXA-48-Like β-Lactamase.
Topics: Aged, 80 and over; Amino Acid Substitution; Anti-Bacterial Agents; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Ertapenem; Humans; Hydrolysis; Imipenem; Isoenzymes; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Mutagenesis, Insertional; Plasmids; Sequence Deletion | 2018 |
Molecular epidemiology of ESBL-producing Klebsiella pneumoniae isolates in intensive care units of a tertiary care hospital, North of Iran.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Child; Child, Preschool; Clavulanic Acid; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Iran; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Nalidixic Acid; Tertiary Care Centers | 2018 |
AmpC beta-lactamases in Klebsiella pneumoniae: An emerging threat to the paediatric patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefoperazone; Cefoxitin; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Pakistan; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2018 |
Elucidating the survival and response of carbapenem resistant Klebsiella pneumoniae after exposure to imipenem at sub-lethal concentrations.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Drug Resistance, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype | 2018 |
Degradable antimicrobial polycarbonates with unexpected activity and selectivity for treating multidrug-resistant Klebsiella pneumoniae lung infection in mice.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biocompatible Materials; Cell Line; Cell Membrane; Cytosol; Drug Resistance, Multiple, Bacterial; Epithelial Cells; Female; Guanidine; Humans; Imipenem; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lung Diseases; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumonia, Bacterial; Polycarboxylate Cement; Polymers; Protein Binding | 2019 |
Comparison of adhesin genes expression among Klebsiella oxytoca ESBL-non-producers in planktonic and biofilm mode of growth, and imipenem sublethal exposure.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Biofilms; Carbapenems; Gene Expression Regulation, Bacterial; Genes, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella oxytoca; Microbial Sensitivity Tests; Phenotype | 2019 |
Treatment with andrographolide sulfonate provides additional benefits to imipenem in a mouse model of Klebsiella pneumoniae pneumonia.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Cell Movement; Disease Models, Animal; Diterpenes; Humans; Imipenem; Inflammation; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice, Inbred C57BL; Monocyte Chemoattractant Proteins; NLR Family, Pyrin Domain-Containing 3 Protein; Pneumonia; Survival Analysis; THP-1 Cells | 2019 |
Combined disc methods for the detection of KPC- and/or VIM-positive Klebsiella pneumoniae: improving reliability for the double carbapenemase producers.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cloxacillin; Europe; Greece; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Picolinic Acids; Reproducibility of Results; Thienamycins | 2013 |
Meropenem resistance in imipenem-susceptible meropenem-resistant Klebsiella pneumoniae isolates not detected by rapid automated testing systems.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Diagnostic Errors; Humans; Imipenem; Japan; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2013 |
In vitro activity of fosfomycin in combination with imipenem, meropenem, colistin and tigecycline against OXA 48-positive Klebsiella pneumoniae strains.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Colistin; Disk Diffusion Antimicrobial Tests; Drug Synergism; Fosfomycin; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Minocycline; Molecular Typing; Real-Time Polymerase Chain Reaction; Thienamycins; Tigecycline | 2013 |
Synergistic antibiotic combinations for colistin-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Ceftazidime; Colistin; Drug Resistance, Bacterial; Drug Synergism; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tobramycin | 2013 |
The first case of septicemia caused by imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae.
Topics: Aged; Drug Resistance, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Phenotype; Sepsis; Thienamycins | 2013 |
[Investigation of plasmid mediated AmpC beta-lactamases among Escherichia coli and Klebsiella pneumoniae isolated from blood cultures].
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Cefotaxime; Cefoxitin; Ceftazidime; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Plasmids | 2013 |
Activity of imipenem against Klebsiella pneumoniae biofilms in vitro and in vivo.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Dermis; Ear; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Rabbits; Re-Epithelialization | 2014 |
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial; End Stage Liver Disease; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Preoperative Period; Risk Factors; Severity of Illness Index | 2014 |
Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Female; Genome, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Polymerase Chain Reaction; Public Health Surveillance; Survival Analysis; Thienamycins; Treatment Outcome | 2014 |
Molecular epidemiology of OXA-48-producing Klebsiella pneumoniae in France.
Topics: Anti-Bacterial Agents; beta-Lactamases; Electrophoresis, Gel, Pulsed-Field; France; Genotype; Hospitals; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Molecular Epidemiology; Multilocus Sequence Typing; Thienamycins | 2014 |
Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cephalosporins; China; Drug Resistance, Bacterial; Gram-Negative Bacteria; Hospitals, University; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins | 2015 |
Endogenous endophthalmitis complicated by pyogenic liver abscess: a review of 17 years' experience at a single center.
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Diabetes Complications; Endophthalmitis; Female; Humans; Imipenem; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess, Pyogenic; Male; Middle Aged; Risk Factors; Treatment Outcome | 2014 |
First report in China of Enterobacteriaceae clinical isolates coharboring blaNDM-1 and blaIMP-4 drug resistance genes.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Plasmids; Quinolones; Thienamycins | 2015 |
Pharmacodynamics of imipenem in combination with β-lactamase inhibitor MK7655 in a murine thigh model.
Topics: Animals; beta-Lactamase Inhibitors; Disease Models, Animal; Female; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Thigh | 2015 |
Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Containment of Biohazards; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Imipenem; Incidence; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Phenotype; Prevalence; Prospective Studies; Republic of Korea; Retrospective Studies; Thienamycins | 2014 |
Characterization of extended-spectrum beta-lactamase, carbapenemase, and plasmid quinolone determinants in Klebsiella pneumoniae isolates carrying distinct types of 16S rRNA methylase genes, and their association with mobile genetic elements.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; China; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Imipenem; Integrons; Interspersed Repetitive Sequences; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Quinolones; RNA, Ribosomal, 16S; tRNA Methyltransferases | 2015 |
Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Crystallography, X-Ray; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Models, Molecular; Pseudomonas aeruginosa; Pseudomonas Infections; Sulfhydryl Compounds | 2015 |
The Role of OmpK35, OmpK36 Porins, and Production of β-Lactamases on Imipenem Susceptibility in Klebsiella pneumoniae Clinical Isolates, Cairo, Egypt.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefoxitin; Egypt; Gene Expression Regulation, Bacterial; Hospitals, University; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins | 2015 |
In Vitro Activity of Imipenem and Colistin against a Carbapenem-Resistant Klebsiella pneumoniae Isolate Coproducing SHV-31, CMY-2, and DHA-1.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Hip; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Porins | 2015 |
Trends in Susceptibility Rates and Extended-Spectrum β-Lactamase Production of Klebsiella pneumoniae in Bloodstream Infections Across the United States Veterans Affairs Healthcare System.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cefepime; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ertapenem; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; United States; United States Department of Veterans Affairs | 2015 |
Efficacy of Appropriate Antimicrobial Therapy on the Survival of Patients With Carbapenem Nonsusceptible Klebsiella Pneumoniae Infection: A Multicenter Study in Taiwan.
Topics: Aged; Anti-Infective Agents; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Medication Therapy Management; Meropenem; Microbial Sensitivity Tests; Middle Aged; Outcome Assessment, Health Care; Pneumonia; Proportional Hazards Models; Severity of Illness Index; Taiwan; Thienamycins | 2015 |
Biochemical Characterization of VIM-39, a VIM-1-Like Metallo-β-Lactamase Variant from a Multidrug-Resistant Klebsiella pneumoniae Isolate from Greece.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Biotransformation; Cephalothin; Gene Expression; Greece; Humans; Hydrolysis; Imipenem; Isoenzymes; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2015 |
EMERGENCY ROOM: AN UNRECOGNIZED SOURCE OF EXTENDED-SPECTRUM β-LACTAMASE PRODUCING ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Plasmids; Thailand; Thienamycins; Young Adult | 2015 |
Identification and Characterization of Imipenem-Resistant Klebsiella pneumoniae and Susceptible Klebsiella variicola Isolates Obtained from the Same Patient.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny; Virulence Factors | 2016 |
Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Blood; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Nursing Homes; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus Infections; Proteus mirabilis; Retrospective Studies; Sputum; Taiwan; Thienamycins; Urine | 2016 |
Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cephalosporins; Drug Therapy, Combination; Female; Humans; Imipenem; Immunosuppressive Agents; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Retrospective Studies; Survival Analysis; Thienamycins; Treatment Outcome | 2016 |
Emergence and interhospital spread of OXA-48-producing Klebsiella pneumoniae ST395 clone in Western Hungary.
Topics: beta-Lactamases; Cross Infection; Genotype; Hospitals; Humans; Hungary; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Molecular Typing; Thienamycins | 2017 |
Rapid increase in resistance to third generation cephalosporins, imipenem and co-resistance in Klebsiella pneumoniae from isolated from 7,140 blood-cultures (2010-2014) using EARS-Net data in Spain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Catchment Area, Health; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Population Surveillance; Spain; Young Adult | 2017 |
Successful Treatment of Urinary Tract Infection in Kidney Transplant Recipients Caused by Multiresistant Klebsiella pneumoniae Producing New Delhi Metallo-Beta-Lactamase (NDM-1) With Strains Genotyping.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cilastatin; Cilastatin, Imipenem Drug Combination; Colistin; Drug Combinations; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Fosfomycin; Genotype; Gentamicins; Humans; Imipenem; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Transplant Recipients; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2016 |
High minimum inhibitory concentration of imipenem as a predictor of fatal outcome in patients with carbapenem non-susceptible Klebsiella pneumoniae.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Female; Hospitals, General; Hospitals, Veterans; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Survival Analysis; Taiwan; Treatment Outcome; Young Adult | 2016 |
Clonal Spread of Colistin-Resistant Klebsiella pneumoniae Coproducing KPC and VIM Carbapenemases in Neonates at a Tunisian University Hospital.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Chloramphenicol; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Ertapenem; Female; Gene Expression; Hospitals, University; Humans; Imipenem; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Minocycline; Retrospective Studies; Survival Analysis; Tigecycline; Tunisia | 2017 |
Antibiotic Sensitivity pattern of Bacterial Isolates of Neonatal Septicemia in Peshawar, Pakistan.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enoxacin; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant, Low Birth Weight; Infant, Newborn; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Neonatal Sepsis; Ofloxacin; Pakistan; Proteus; Proteus Infections; Pseudomonas; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis | 2016 |
Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Critical Care; Doripenem; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Genotype; Humans; Imipenem; Klebsiella; Klebsiella Infections; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Thienamycins; United States | 2017 |
Emergence of Serratia liquefaciens and Klebsiella oxytoca with metallo-beta-lactamase-encoding IncW plasmids: further spread of the blaVIM-1-carrying integron In-e541.
Topics: Anti-Bacterial Agents; beta-Lactamases; Biomarkers; Conjugation, Genetic; Drug Resistance, Bacterial; Greece; Humans; Imipenem; Integrons; Klebsiella Infections; Klebsiella oxytoca; Microbial Sensitivity Tests; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Serratia Infections; Serratia liquefaciens | 2008 |
Combined porin loss and extended spectrum beta-lactamase production is associated with an increasing imipenem minimal inhibitory concentration in clinical Klebsiella pneumoniae strains.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; China; Drug Resistance, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins | 2009 |
Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Female; Genes, Bacterial; Humans; Imipenem; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Polymerase Chain Reaction; Thienamycins; Treatment Failure; Treatment Outcome; Young Adult | 2009 |
Prevalence, antibiotic susceptibility pattern and production of extended-spectrum beta-lactamases amongst clinical isolates of Klebsiella pneumoniae at Armed Forces Hospital in Saudi Arabia.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Prevalence; Saudi Arabia; Tetracycline Resistance | 2009 |
Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control study.
Topics: Aged; Anti-Bacterial Agents; Ascites; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Liver Cirrhosis; Male; Middle Aged; Peritonitis; Retrospective Studies; Risk Factors; Treatment Failure | 2009 |
The prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates from a general hospital in Iran.
Topics: Anti-Bacterial Agents; beta-Lactamases; Escherichia coli; Escherichia coli Infections; Female; Hospitals, General; Humans; Imipenem; Iran; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Prevalence | 2009 |
Characterization of multidrug-resistant and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains from Malaysian hospitals.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Conjugation, Genetic; Cross Infection; DNA Fingerprinting; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, Public; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Malaysia; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction | 2009 |
First isolation of a VIM-producing Klebsiella pneumoniae from a seven-year-old child in Venezuela.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Child; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Quinolones; Thienamycins; Urine; Venezuela | 2008 |
In vivo selection of imipenem-resistant Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-15 and plasmid-encoded DHA-1 cephalosporinase.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Selection, Genetic | 2010 |
Imipenem-associated encephalopathy: alert to physicians.
Topics: Aged; Anti-Bacterial Agents; Brain Diseases; Humans; Imipenem; Klebsiella Infections; Male; Sepsis | 2010 |
The ongoing challenge of acquired carbapenemases: a hospital outbreak of Klebsiella pneumoniae simultaneously producing VIM-1 and KPC-2.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cross Infection; Disease Outbreaks; Greece; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Thienamycins | 2010 |
Increase of ceftazidime- and fluoroquinolone-resistant Klebsiella pneumoniae and imipenem-resistant Acinetobacter spp. in Korea: analysis of KONSAR study data from 2005 and 2007.
Topics: Acinetobacter; Bacterial Infections; Ceftazidime; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Pseudomonas aeruginosa; Republic of Korea; Vancomycin | 2010 |
Severe systemic sepsis due to pyogenic liver abscess.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fatal Outcome; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess, Pyogenic; Male; Middle Aged; Sepsis | 2012 |
[Iatrogenic meningitis after diagnosis lumbar puncture: 3 cases reports in the paediatric Children's Hospital of Tunis].
Topics: beta-Lactam Resistance; Brain Abscess; Brain Damage, Chronic; Ciprofloxacin; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fosfomycin; Humans; Hydrocephalus; Iatrogenic Disease; Imipenem; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis, Bacterial; Muscle Hypotonia; Seizures; Serratia Infections; Serratia marcescens; Spinal Puncture; Subdural Effusion; Tunisia | 2011 |
Comparative effects of carbapenems on bacterial load and host immune response in a Klebsiella pneumoniae murine pneumonia model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; Carbapenems; Cytokines; Disease Models, Animal; Doripenem; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lung; Meropenem; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins; Treatment Outcome | 2011 |
Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003-2004.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; France; Hospital Bed Capacity, 500 and over; Humans; Imipenem; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Microbial Sensitivity Tests | 2010 |
Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
Topics: Age Factors; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Chi-Square Distribution; Confidence Intervals; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Risk Factors; Thienamycins | 2011 |
Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Doripenem; Electrophoresis, Gel, Pulsed-Field; Ertapenem; Genotype; Hospitals, Urban; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Phylogeny; Polymerase Chain Reaction; Sensitivity and Specificity; Thienamycins; United States | 2011 |
[Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2011 |
Sepsis in neonates due to imipenem-resistant Klebsiella pneumoniae producing NDM-1 in India.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Humans; Imipenem; India; Infant, Newborn; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sepsis | 2011 |
Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome | 2011 |
Evaluation of a real-time PCR assay for the detection of the Klebsiella pneumoniae carbapenemase genes in microbiological samples in comparison with the modified Hodge test.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; DNA, Bacterial; Ertapenem; Genes, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Predictive Value of Tests | 2011 |
Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infections and molecular characterization of ertapenem-resistant isolates.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2011 |
Emergence in Japan of an imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae carrying blaIMP-6.
Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Conjugation, Genetic; Female; Gene Transfer, Horizontal; Humans; Imipenem; Japan; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Plasmids; Thienamycins | 2012 |
Rapid detection of blaIMP-6 by amplification refractory mutation system.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Bacterial; Humans; Imipenem; Japan; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction | 2012 |
Efficacy of imipenem for the treatment of bacteremia due to an OXA-48-producing Klebsiella pneumoniae isolate.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; DNA, Bacterial; Female; Genotype; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 2012 |
Characterization of a novel Klebsiella pneumoniae sequence type 476 carrying both bla KPC-2 and bla IMP-4.
Topics: Anti-Bacterial Agents; beta-Lactamases; Blotting, Southern; China; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Imipenem; Infant; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; Thienamycins; Urine | 2012 |
Broad-spectrum β-lactam antibiotics for treating experimental peritonitis in mice due to Klebsiella pneumoniae producing the carbapenemase OXA-48.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Ertapenem; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lethal Dose 50; Mice; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Survival Rate | 2012 |
Novel modeling framework to guide design of optimal dosing strategies for β-lactamase inhibitors.
Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; Computer Simulation; Drug Administration Schedule; Drug Combinations; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Membranes, Artificial; Microbial Sensitivity Tests; Models, Statistical; Practice Guidelines as Topic | 2012 |
Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility.
Topics: Adult; Bacteremia; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Retrospective Studies; Thienamycins; Young Adult | 2012 |
A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit.
Topics: Anti-Bacterial Agents; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Care; Cross Infection; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Surgical Wound Infection | 2012 |
Sequence type 101 (ST101) as the predominant carbapenem-non-susceptible Klebsiella pneumoniae clone in an acute general hospital in Italy.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Hospitals, General; Humans; Imipenem; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2012 |
Occurrence and phenotypic detection of class A carbapenemases among Escherichia coli and Klebsiella pneumoniae blood isolates at a tertiary care center.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Prevalence; Sepsis; Tertiary Care Centers; Thienamycins | 2013 |
Inter-hospital outbreak of Klebsiella pneumoniae producing KPC-2 carbapenemase in Ireland.
Topics: beta-Lactamases; beta-Lactams; Disease Outbreaks; Ertapenem; Genes, Bacterial; Hospitals; Humans; Imipenem; Ireland; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Polymerase Chain Reaction; Thienamycins | 2012 |
Carbapenem non-susceptible Klebsiella pneumoniae from Micronet network hospitals, Italy, 2009 to 2012.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Hospitals; Humans; Imipenem; Italy; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Sentinel Surveillance; Thienamycins | 2012 |
Molecular typing and resistance mechanisms of imipenem-non-susceptible Klebsiella pneumoniae in Taiwan: results from the Taiwan surveillance of antibiotic resistance (TSAR) study, 2002-2009.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Population Surveillance; Taiwan | 2013 |
Epidemiology and resistance mechanisms to imipenem in Klebsiella pneumoniae: a multicenter study.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporinase; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2013 |
[Comparison of ertapenem-EMB Agar with traditional methods for screening carbapenem-resistant Klebsiella pneumoniae from rectal swabs].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Culture Media; Doripenem; Drug Resistance, Bacterial; Ertapenem; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Multiplex Polymerase Chain Reaction; Rectum; Sensitivity and Specificity; Thienamycins; Time Factors | 2012 |
[Distribution of bacteria and analysis of their sensibility to antibiotics in patients with hospital-acquired pneumonia].
Topics: Adult; Aged; Aged, 80 and over; Cefoperazone; Ceftriaxone; Cross Infection; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus epidermidis | 2000 |
Attributable costs and length of stay of an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae outbreak in a neonatal intensive care unit.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Disease Outbreaks; Hospital Costs; Humans; Imipenem; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; New York City; Sentinel Surveillance | 2003 |
Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Drug Resistance, Bacterial; Drug Utilization; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Multivariate Analysis | 2004 |
Comparison of trends of resistance rates over 3 years calculated from results for all isolates and for the first isolate of a given species from a patient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Cefotaxime; Drug Resistance, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 2004 |
First isolation of metallo-beta-lactamase-producing multiresistant Klebsiella pneumoniae from a patient in Brazil.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Brazil; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests | 2005 |
Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Colony Count, Microbial; Guinea Pigs; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lung; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Porins; Thienamycins; Treatment Outcome | 2005 |
Efficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 beta-Lactamase.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Disease Models, Animal; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Porins; Treatment Outcome | 2005 |
In vivo transfer of plasmid-encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an infant and selection of impermeability to imipenem in K. pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Conjugation, Genetic; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids; Selection, Genetic | 2005 |
Evaluation of techniques for detection of carbapenem-resistant Klebsiella pneumoniae in stool surveillance cultures.
Topics: Bacteriological Techniques; Carbapenems; Culture Media; Drug Resistance, Bacterial; Evaluation Studies as Topic; Feces; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2005 |
Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance.
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Fluoroquinolones; Gammaproteobacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Korea; Microbial Sensitivity Tests; Population Surveillance; Vancomycin; Vancomycin Resistance | 2006 |
Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Colony Count, Microbial; Imipenem; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Plasmids; Pneumonia, Bacterial; Porins; Rats; Rats, Wistar; Thienamycins; Treatment Outcome | 2006 |
Prevalence and mechanisms of decreased susceptibility to carbapenems in Klebsiella pneumoniae isolates.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Electrophoresis, Polyacrylamide Gel; Humans; Imipenem; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Korea; Mass Spectrometry; Meropenem; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Porins; Prevalence; Sequence Analysis, DNA; Thienamycins | 2007 |
[Sanfetrinem, the member of trinems--in vitro activity against Klebsiella pneumoniae producing ESBL].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lactams; Microbial Sensitivity Tests | 2006 |
VIM-1-producing Klebsiella pneumoniae bloodstream infections: analysis of 28 cases.
Topics: Adult; Aged; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Regression Analysis; Retrospective Studies; Survival Rate; Treatment Outcome | 2007 |
The effect of amikacin and imipenem alone and in combination against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.
Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactamases; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Microbial Sensitivity Tests | 2007 |
Porin loss and GES-type extended-spectrum beta-lactamase primarily responsible for reduced susceptibility to imipenem.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Porins | 2007 |
Imipenem-resistance in Klebsiella pneumoniae in Malaysia due to loss of OmpK36 outer membrane protein coupled with AmpC hyperproduction.
Topics: Adult; Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; Drug Resistance, Bacterial; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Malaysia; Porins | 2007 |
Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Military Personnel | 2007 |
Effects of imipenem-cilastatin, ertapenem, piperacillin-tazobactam, and ceftriaxone treatments on persistence of intestinal colonization by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae strains in mice.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Intestines; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2007 |
Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cephalosporins; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Electroporation; Ertapenem; Female; Genotype; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins; Reverse Transcriptase Polymerase Chain Reaction; Thienamycins | 2007 |
[Antibiotic susceptibility and molecular mechanisms of cephalosporins resistance in Klebsiella isolates from patients with hospital-acquired infections].
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporin Resistance; Cross Infection; Humans; Imipenem; Klebsiella; Klebsiella Infections; Meropenem; Thienamycins | 2006 |
[Postoperative penicillin-resistant streptococcus pneumonia in lung cancer patient].
Topics: Aged; Carcinoma, Squamous Cell; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Fatal Outcome; Humans; Imipenem; Klebsiella Infections; Lung Neoplasms; Male; Penicillin Resistance; Pneumonia, Pneumococcal; Postoperative Complications; Sepsis; Streptococcus pneumoniae; Ventilators, Mechanical | 2008 |
Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactamases; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Plasmids; Porins; Tigecycline | 2008 |
Antagonism by chloramphenicol of broad-spectrum beta-lactam antibiotics against Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Chloramphenicol; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Thienamycins; Time Factors | 1984 |
Emergence of resistance to imipenem in Enterobacter isolates masquerading as Klebsiella pneumoniae during therapy with imipenem/cilastatin.
Topics: Aged; Cefoxitin; Cilastatin; Diagnosis, Differential; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male | 1993 |
Safety of imipenem in neonates.
Topics: Dose-Response Relationship, Drug; Humans; Imipenem; Incidence; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; Sepsis; Thienamycins; Treatment Outcome | 1995 |
[In vitro and in vivo activities of sulopenem compared with those of imipenem and cephalosporins].
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; Cefotaxime; Ceftizoxime; Cephalosporins; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Guinea Pigs; Imipenem; Klebsiella Infections; Lactams; Lung Diseases; Mice; Mice, Inbred ICR; Thienamycins | 1996 |
Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.
Topics: Amino Acid Sequence; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; Blotting, Southern; Carbapenems; Disease Outbreaks; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Infant; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids | 1997 |
Prolonged continuous i.v. "desensitization" in Tienam hypersensitivity.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Desensitization, Immunologic; Drug Combinations; Drug Hypersensitivity; Drug Therapy, Combination; Female; Humans; Imipenem; Infusions, Intravenous; Klebsiella Infections; Middle Aged | 1997 |
Emergence of a carbapenem-resistant Klebsiella pneumoniae.
Topics: beta-Lactam Resistance; Disease Outbreaks; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle Aged; Scotland; Thienamycins | 1997 |
Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates.
Topics: Anti-Infective Agents; beta-Lactamase Inhibitors; Cilastatin; Ciprofloxacin; Cross Infection; Drug Combinations; Drug Resistance, Microbial; Drug Resistance, Multiple; Enzyme Inhibitors; Female; Humans; Imipenem; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Protease Inhibitors; Retrospective Studies; Tazobactam; Thienamycins | 1998 |
[Comparative activity of cefepime, ceftazidime and imipenem in a mouse infection caused by Klebsiella pneumoniae producing a broad spectrum beta-lactamase].
Topics: Animals; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Colony Count, Microbial; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Spleen; Thienamycins | 1998 |
In-vitro selection of porin-deficient mutants of two strains of Klebsiella pneumoniae with reduced susceptibilities to meropenem, but not to imipenem.
Topics: beta-Lactamases; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Porins; Thienamycins | 1998 |
Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae.
Topics: Adult; Aged; Aged, 80 and over; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Thienamycins | 1999 |
In vitro and in vivo activities of amikacin, cefepime, amikacin plus cefepime, and imipenem against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.
Topics: Amikacin; Animals; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Drug Therapy, Combination; Imipenem; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Survival Analysis | 2001 |
The in vitro effect of imipenem and ofloxacin on enzymic activity of Klebsiella strains.
Topics: Anti-Infective Agents; Humans; Imipenem; Klebsiella; Klebsiella Infections; Lipase; Microbial Sensitivity Tests; Ofloxacin; Thienamycins; Urease | 2000 |
[Medical treatment of infected pancreatic necrosis].
Topics: Aged; Ciprofloxacin; Combined Modality Therapy; Drug Therapy, Combination; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Pancreatitis, Acute Necrotizing; Parenteral Nutrition, Total; Trimethoprim, Sulfamethoxazole Drug Combination | 2001 |
Umbilical catheter-related resistant Klebsiella septicaemia in a pre-term infant successfully treated with imipenem via the catheter.
Topics: Bacteremia; Catheterization; Drug Resistance, Microbial; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Klebsiella Infections; Male; Umbilicus | 1992 |
Pharmacokinetic evidence of imipenem efficacy in the treatment of Klebsiella pneumoniae nosocomial meningitis.
Topics: Aged; Cross Infection; Humans; Imipenem; Klebsiella Infections; Male; Meningitis, Bacterial | 1991 |
[Evaluation of imipenem/cilastatin sodium in the treatment of respiratory tract infections].
Topics: Adult; Aged; Aged, 80 and over; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Imipenem; Klebsiella Infections; Male; Middle Aged; Pseudomonas; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus | 1990 |
Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models.
Topics: Animals; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gentamicins; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lung; Mice; Mice, Inbred ICR; Muscles; Pneumonia | 1989 |
Bactericidal effect of ceftriaxone versus imipenem plus cilastatin in bronchial secretion.
Topics: Aged; Bronchial Diseases; Ceftriaxone; Cilastatin; Drug Administration Schedule; Drug Combinations; Haemophilus Infections; Haemophilus influenzae; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Sputum; Streptococcal Infections; Streptococcus pneumoniae | 1988 |
Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis.
Topics: Agranulocytosis; Amikacin; Animals; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Imipenem; Kanamycin; Kinetics; Klebsiella Infections; Microbial Sensitivity Tests; Neutropenia; Pseudomonas Infections; Rats; Sepsis; Serratia marcescens; Thienamycins | 1986 |